ID

14453

Description

Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193245

Link

https://clinicaltrials.gov/show/NCT00193245

Keywords

Versions (1)
  1. 4/15/16 4/15/16 -
Uploaded on

April 15, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lung Cancer NCT00193245

English

Eligibility Lung Cancer NCT00193245

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Description

Inclusion criteria

Data type

boolean

Alias
UMLS CUI [1]
C1512693
relapsed or progressive disease
Description

Relapsed or progressive disease

Data type

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C1335499
stage iiib (not candidate for combined modality) or iv
Description

Lung cancer stage

Data type

boolean

Alias
UMLS CUI [1,1]
C0242379
UMLS CUI [1,2]
C1515169
no more than one prior chemotherapy regimen
Description

Number of chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0237753
able to perform activities of daily living without assistance
Description

No assistance in daily live

Data type

boolean

Alias
UMLS CUI [1,1]
C0509063
UMLS CUI [1,2]
C1518422
measurable disease outside of radiation port
Description

Comorbidity site

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1515974
adequate bone marrow, liver and kidney function
Description

Bone marrow, liver and kidney function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0678852
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
must understand study and sign informed consent prior to enrollment
Description

Cognitive function and informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0392335
UMLS CUI [2]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Exclusion criteria

Data type

boolean

Alias
UMLS CUI [1]
C0680251
prior treatment with topotecan or docetaxel
Description

Topotecan or docetaxel

Data type

boolean

Alias
UMLS CUI [1]
C0146224
UMLS CUI [2]
C0246415
uncontrolled brain metastases
Description

Brain metastases

Data type

boolean

Alias
UMLS CUI [1]
C0220650
moderate peripheral neuropathy
Description

Peripheral neuropathy

Data type

boolean

Alias
UMLS CUI [1]
C0031117
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

Additional inclusion/ exclusion criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C1524062
UMLS CUI [1,2]
C1512693
UMLS CUI [2,1]
C1524062
UMLS CUI [2,2]
C0680251
Back to the top of the page

Similar models

Eligibility Lung Cancer NCT00193245

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Inclusion criteria
Item
to be included in this study, you must meet the following criteria:
boolean
C1512693 (UMLS CUI [1])
Relapsed or progressive disease
Item
relapsed or progressive disease
boolean
C0277556 (UMLS CUI [1])
C1335499 (UMLS CUI [2])
Lung cancer stage
Item
stage iiib (not candidate for combined modality) or iv
boolean
C0242379 (UMLS CUI [1,1])
C1515169 (UMLS CUI [1,2])
Number of chemotherapy
Item
no more than one prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
No assistance in daily live
Item
able to perform activities of daily living without assistance
boolean
C0509063 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
Comorbidity site
Item
measurable disease outside of radiation port
boolean
C0009488 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
Bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0678852 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Cognitive function and informed consent
Item
must understand study and sign informed consent prior to enrollment
boolean
C0392335 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Exclusion criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
C0680251 (UMLS CUI [1])
Topotecan or docetaxel
Item
prior treatment with topotecan or docetaxel
boolean
C0146224 (UMLS CUI [1])
C0246415 (UMLS CUI [2])
Brain metastases
Item
uncontrolled brain metastases
boolean
C0220650 (UMLS CUI [1])
Peripheral neuropathy
Item
moderate peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
Additional inclusion/ exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1524062 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C1524062 (UMLS CUI [2,1])
C0680251 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial